HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2- methoxy- 5- (2- (3,4,5- trimethoxyphenyl)thiophen- 3- yl)aniline

a microtubule modulators; structure in first source

Also Known As:

DAT-230

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Aniline Compounds: 46
    - 2-methoxy-5-(2-(3,4,5-trimethoxyphenyl)thiophen-3-yl)aniline: 2
- Sulfur Compounds: 278
  - Thiophenes: 257
    - 2-methoxy-5-(2-(3,4,5-trimethoxyphenyl)thiophen-3-yl)aniline: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Thiophenes: 257
    - 2-methoxy-5-(2-(3,4,5-trimethoxyphenyl)thiophen-3-yl)aniline: 2

Experts

1.	Qi, Huan: 2 articles (01/2013 - 08/2012)
2.	Qiao, Foxiao: 2 articles (01/2013 - 08/2012)
3.	Wang, Haifeng: 2 articles (01/2013 - 08/2012)
4.	Wu, Yingliang: 2 articles (01/2013 - 08/2012)
5.	Zhang, Weige: 2 articles (01/2013 - 08/2012)
6.	Zuo, Daiying: 2 articles (01/2013 - 08/2012)
7.	Li, Zengqiang: 1 article (01/2013)
8.	Shen, Xueqi: 1 article (08/2012)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2013 - "In conclusion, DAT-230 is a promising microtubule inhibitor with great anti-tumor activity to SGC-7901, in vitro and in vivo. " 08/01/2012 - "DAT-230 exhibited potent anti-proliferative activity against various cancer cells. " 08/01/2012 - "DAT-230, a novel microtubule inhibitor, exhibits potent anti-tumor activity by inducing G2/M phase arrest, apoptosis in vitro and perfusion decrease in vivo to HT-1080." 01/01/2013 - "In vivo, DAT-230 delayed tumor growth in BALB/c nude mice with human gastric adenocarcinoma xenografts. " 08/01/2012 - "In vivo, DAT-230 delayed tumor growth, induced tumor perfusion decrease and extensive hemorrhagic-necrosis. "
2.	Necrosis 08/01/2012 - "In vivo, DAT-230 delayed tumor growth, induced tumor perfusion decrease and extensive hemorrhagic-necrosis. "
3.	Fibrosarcoma 08/01/2012 - "DAT-230 is a promising microtubule inhibitor that has great potential for the treatment of fibrosarcoma in vitro and in vivo. "
4.	Adenocarcinoma 01/01/2013 - "In vivo, DAT-230 delayed tumor growth in BALB/c nude mice with human gastric adenocarcinoma xenografts. "